134 related articles for article (PubMed ID: 36476660)
1. The Glasgow Microenvironment Score and risk and site of recurrence in TNM I-III colorectal cancer.
Alexander PG; van Wyk HC; Pennel KAF; Hay J; McMillan DC; Horgan PG; Roxburgh CSD; Edwards J; Park JH
Br J Cancer; 2023 Feb; 128(4):556-567. PubMed ID: 36476660
[TBL] [Abstract][Full Text] [Related]
2. The Glasgow Microenvironment Score associates with prognosis and adjuvant chemotherapy response in colorectal cancer.
Alexander PG; Roseweir AK; Pennel KAF; van Wyk HC; Powell AGMT; McMillan DC; Horgan PG; Kelly C; Hay J; Sansom O; Harkin A; Roxburgh CSD; Graham J; Church DN; Tomlinson I; Saunders M; Iveson TJ; Edwards J; Park JH
Br J Cancer; 2021 Feb; 124(4):786-796. PubMed ID: 33223535
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a tumor microenvironment-based prognostic score in primary operable colorectal cancer.
Park JH; McMillan DC; Powell AG; Richards CH; Horgan PG; Edwards J; Roxburgh CS
Clin Cancer Res; 2015 Feb; 21(4):882-8. PubMed ID: 25473000
[TBL] [Abstract][Full Text] [Related]
4. The relationship between tumour budding, the tumour microenvironment and survival in patients with primary operable colorectal cancer.
van Wyk HC; Park JH; Edwards J; Horgan PG; McMillan DC; Going JJ
Br J Cancer; 2016 Jul; 115(2):156-63. PubMed ID: 27299960
[TBL] [Abstract][Full Text] [Related]
5. The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer.
Park JH; Richards CH; McMillan DC; Horgan PG; Roxburgh CSD
Ann Oncol; 2014 Mar; 25(3):644-651. PubMed ID: 24458470
[TBL] [Abstract][Full Text] [Related]
6. The Glasgow Microenvironment Score: an exemplar of contemporary biomarker evolution in colorectal cancer.
Knight K; Bigley C; Pennel K; Hay J; Maka N; McMillan D; Park J; Roxburgh C; Edwards J
J Pathol Clin Res; 2024 Jul; 10(4):e12385. PubMed ID: 38853386
[TBL] [Abstract][Full Text] [Related]
7. Prognostic effects of histology-based tumour microenvironment scores in resected distal bile duct cancer.
Hwang HW; Kim JY; Lee SE; Choi YS; Hong SH; Lee TJ; Kim MK; Park ES; Hong SA
Histopathology; 2020 Sep; 77(3):402-412. PubMed ID: 32473032
[TBL] [Abstract][Full Text] [Related]
8. Utility of Glasgow Microenvironment Score as a prognostic tool in colorectal carcinoma.
Ahuja M; Dwarak A; Mallya V; Mandal S; Tomar R; Khurana N; Lal P; Singh K
J Cancer Res Ther; 2023 Apr; 19(Supplement):S172-S176. PubMed ID: 37147995
[TBL] [Abstract][Full Text] [Related]
9. Tumor microenvironmental factors have prognostic significances in advanced gastric cancer.
Ahn B; Chae YS; Kim CH; Lee Y; Lee JH; Kim JY
APMIS; 2018 Oct; 126(10):814-821. PubMed ID: 30264431
[TBL] [Abstract][Full Text] [Related]
10. The relationship between the Glasgow Microenvironment Score and markers of epithelial-mesenchymal transition in TNM II-III colorectal cancer.
Alexander PG; Matly AAM; Jirapongwattana N; Pennel KAF; van Wyk HC; McMillan DC; Horgan PG; Roxburgh CSD; Thuwajit C; Roseweir AK; Quinn J; Park JH; Edwards J
Hum Pathol; 2022 Sep; 127():1-11. PubMed ID: 35623467
[TBL] [Abstract][Full Text] [Related]
11. Peritumoral tertiary lymphoid structure and tumor stroma percentage predict the prognosis of patients with non-metastatic colorectal cancer.
Wang Q; Shen X; An R; Bai J; Dong J; Cai H; Zhu H; Zhong W; Chen W; Liu A; Du J
Front Immunol; 2022; 13():962056. PubMed ID: 36189233
[TBL] [Abstract][Full Text] [Related]
12. The Relationship Between Tumor Budding, Tumor Microenvironment, and Survival in Patients with Primary Operable Colorectal Cancer.
van Wyk HC; Roseweir A; Alexander P; Park JH; Horgan PG; McMillan DC; Edwards J
Ann Surg Oncol; 2019 Dec; 26(13):4397-4404. PubMed ID: 31605345
[TBL] [Abstract][Full Text] [Related]
13. Histopathological tumour microenvironment score independently predicts outcome in primary operable colorectal cancer.
Hatthakarnkul P; Pennel K; Alexander P; van Wyk H; Roseweir A; Inthagard J; Hay J; Andersen D; Maka N; Park J; Roxburgh C; Thuwajit C; McMillan D; Edwards J
J Pathol Clin Res; 2024 May; 10(3):e12374. PubMed ID: 38650367
[TBL] [Abstract][Full Text] [Related]
14. Tumour invasiveness, the local and systemic environment and the basis of staging systems in colorectal cancer.
Park JH; van Wyk H; Roxburgh CSD; Horgan PG; Edwards J; McMillan DC
Br J Cancer; 2017 May; 116(11):1444-1450. PubMed ID: 28427085
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value and tumour microenvironment characteristics of the Glasgow Microenvironment Score in primary triple-negative breast cancer.
Lu X; Wang Y; He M; Gou Z
J Clin Pathol; 2024 Jan; 77(2):128-134. PubMed ID: 36600565
[TBL] [Abstract][Full Text] [Related]
16. Stage-based Variation in the Effect of Primary Tumor Side on All Stages of Colorectal Cancer Recurrence and Survival.
Lee MM; MacKinlay A; Semira C; Schieber C; Jimeno Yepes AJ; Lee B; Wong R; Hettiarachchige CKH; Gunn N; Tie J; Wong HL; Skinner I; Jones IT; Keck J; Kosmider S; Tran B; Field K; Gibbs P
Clin Colorectal Cancer; 2018 Sep; 17(3):e569-e577. PubMed ID: 29980491
[TBL] [Abstract][Full Text] [Related]
17. Impact of tumor deposits on the prognosis and chemotherapy efficacy in stage III colorectal cancer patients with different lymph node status: A retrospective cohort study in China.
Li X; An B; Zhao Q; Qi J; Wang W; Zhang D; Li Z; Qin C
Int J Surg; 2018 Aug; 56():188-194. PubMed ID: 29936197
[TBL] [Abstract][Full Text] [Related]
18. Microenvironment, systemic inflammatory response and tumor markers considering consensus molecular subtypes of colorectal cancer.
Jakab A; Patai ÁV; Darvas M; Tormássi-Bély K; Micsik T
Pathol Oncol Res; 2024; 30():1611574. PubMed ID: 38645565
[No Abstract] [Full Text] [Related]
19. An immune, stroma, and epithelial-mesenchymal transition-related signature for predicting recurrence and chemotherapy benefit in stage II-III colorectal cancer.
Cai D; Wang W; Zhong ME; Fan D; Liu X; Li CH; Huang ZP; Zhu Q; Lv MY; Hu C; Duan X; Wu XJ; Gao F
Cancer Med; 2023 Apr; 12(7):8924-8936. PubMed ID: 36629124
[TBL] [Abstract][Full Text] [Related]
20. The relationship between right-sided tumour location, tumour microenvironment, systemic inflammation, adjuvant therapy and survival in patients undergoing surgery for colon and rectal cancer.
Patel M; McSorley ST; Park JH; Roxburgh CSD; Edwards J; Horgan PG; McMillan DC
Br J Cancer; 2018 Mar; 118(5):705-712. PubMed ID: 29337962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]